Protective role of the endothelial isoform of nitric oxide synthase in ANG II-induced inflammatory responses in the kidney

American Journal of Physiology - Renal Physiology

Volumn 305, Issue 7, 2013, Pages

  Whiting, Curtis ^a   Castillo, Alexander ^a   Haque, Mohammed Z ^a   Majid, Dewan S A ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Angiotensin II; Endothelial nitric oxide synthase activity; Hypertension; Renal injury; Superoxide; Tumor necrosis factor

Indexed keywords

ANGIOTENSIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ETANERCEPT; NITRIC OXIDE; TEMPOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; HYPERTENSION; INFLAMMATION; KIDNEY INJURY; MALE; MORTALITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 84884958355     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00024.2013     Document Type: Article

References (54)

1. Agarwal D, Elks CM, Reed SD, Mariappan N, Majid DSA, Francis J. Chronic exercise preserves renal structures and hemodynamics in spontaneously hypertensive rats. Antioxid Redox Signal 16: 139-152, 2012.
2. Alayan J, Ivanovski S, Gemmell E, Ford P, Hamlet S, Farah CS. Deficiency of iNOS contributes to Porphyromonas gingivalis-induced tissue damage. Oral Microbiol Immunol 21: 360-365, 2006.
3. Araujo M, Welch WJ. Oxidative stress and nitric oxide in kidney function. Curr Opin Nephrol Hypertens 15: 72-77, 2006.
4. Bougaki M, Searles RJ, Kida K, Yu J, Buys ES, Ichinose F. Nos3 protects against systemic inflammation and myocardial dysfunction in murine polymicrobial sepsis. Shock 34: 281-290, 2010.
5. Bourraindeloup M, Adamy C, Candiani G, Cailleret M, Bourin MC, Badoual T, Su JB, Adubeiro S, Roudot-Thoraval F, Dubois-Rande JL, Hittinger L, Pecker F. N-acetylcysteine treatment normalizes serum tumor necrosis factor-α level and hinders the progression of cardiac injury in hypertensive rats. Circulation 110: 2003-2009, 2004.
6. 2 receptor. Curr Opin Nephrol Hypertens 14: 67-71, 2005.
7. Coleman JW. Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol 129: 4-10, 2002.
8. 2+-dependent NOS in renal cortex of ANG II-infused hypertensive rats. Am J Physiol Renal Physiol 277: F797-F804, 1999.
9. Chin SY, Wang CT, Majid DS, Navar LG. Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat. Am J Physiol Renal Physiol 274: F876-F882, 1998.
10. De Miguel C, Das S, Lund H, Mattson DL. T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 298: R1136-R1142, 2010.
11. Elmarakby AA, Quigley JE, Imig JD, Pollock JS, Pollock DM. TNF-κ inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol 294: R76-R83, 2008.
12. Elmarakby AA, Quigley JE, Pollock DM, Imig JD. Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension 47: 557-562, 2006.
13. Ferreri NR, Escalante BA, Zhao Y, An SJ, McGiff JC. Angiotensin II induces TNF production by the thick ascending limb: functional implications. Am J Physiol Renal Physiol 274: F148-F155, 1998.
14. Fujihara CK, Malheiros DM, Zatz R, Noronha IL. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 54: 1510-1519, 1998.
15. Fujimoto H, Satoh M, Horike H, Hatta H, Haruna Y, Kobayashi S, Namikoshi T, Arakawa S, Tomita N, Kashihara N. Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production. Hypertens Res 31: 305-313, 2008.
16. Grimm PC, Nickerson P, Gough J, McKenna R, Stern E, Jeffery J, Rush DN. Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol 14: 1662-1668, 2003.
17. Gu JW, Tian N, Shparago M, Tan W, Bailey AP, Manning RD Jr. Renal NF-κB activation and TNF-κ upregulation correlate with saltsensitive hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 291: R1817-R1824, 2006.
18. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449-2460, 2007.
19. Hahn AW, Jonas U, Bühler FR, Resink TJ. Activation of human peripheral monocytes by angiotensin II. FEBS Lett 347: 178-180, 1994.
20. Haque MZ, Majid DS. High salt intake delayed angiotensin II-induced hypertension in mice with a genetic variant of NADPH oxidase. Am J Hypertens 24: 114-118, 2011.
21. Islam MT, Agarwal D, Francis J, Matrougui K, Majid DSA. Inhibition of nitric oxide synthase enhances the production of tumor necrosis factor-α in macrophage cells. FASEB J 25: A1030.7, 2011.
22. Kalra D, Sivasubramanian N, Mann DL. Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway. Circulation 105: 2198-2205, 2002.
23. Kirkebøen KA, Strand OA. The role of nitric oxide in sepsis-an overview. Acta Anaesthesiol Scand 43: 275-288, 1999.
24. Kobori H, Ozawa Y, Suzaki Y, Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 16: 2073-2080, 2005.
25. Kopkan L, Castillo A, Navar LG, Majid DS. Enhanced superoxide generation modulates renal function in angiotensin II-induced hypertensive rats. Am J Physiol Renal Physiol 290: F80-F86, 2006.
26. Kopkan L, Hess A, Husková Z, Cervenka L, Navar LG, Majid DS. High-salt intake enhances superoxide activity in eNOS knockout mice leading to the development of salt sensitivity. Am J Physiol Renal Physiol 299: F656-F663, 2010.
27. Kopkan L, Husková Z, Vanourková Z, Thumová M, Skaroupková P, Cervenka L, Majid DS. Superoxide and its interaction with nitric oxide modulates renal function in prehypertensive Ren-2 transgenic rats. J Hypertens 25: 2257-2265, 2007.
28. Liu F, Wei CC, Wu SJ, Chenier I, Zhang SL, Filep JG, Ingelfinger JR, Chan JSD. Apocynin attenuates tubular apoptosis and tubulointestinal fibrosis in transgenic mice independent of hypertension. Kidney Int 75: 156-166, 2009.
29. López B, Salom MG, Arregui B, Valero F, Fenoy FJ. Role of superoxide in modulating the renal effects of angiotensin II. Hypertension 42: 1150-1156, 2003.
30. Majid DS. Tumor necrosis factor-α, and kidney function: Experimental findings in mice. Adv Exp Med Biol 691: 471-480, 2011.
31. Majid DS, Kopkan L. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension. Clin Exp Pharmacol Physiol 34: 946-952, 2007.
32. Majid DS, Nishiyama A, Jackson KE, Castillo A. Superoxide scavenging attenuates renal responses to ANG II during nitric oxide synthase inhibition in anesthetized dogs. Am J Physiol Renal Physiol 288: F412-F419, 2005.
33. Majid DS, Nishiyama A, Jackson KE, Castillo A. Inhibition of nitric oxide synthase enhances superoxide activity in canine kidney. Am J Physiol Regul Integr Comp Physiol 287: R27-R32, 2004.
34. Mattson DL, James L, Berdan EA, Meister CJ. Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 48: 149-156, 2006.
35. Mervaala E, Müller DN, Schmidt F, Park JK, Gross V, Bader M, Breu V, Ganten D, Haller H, Luft FC. Blood pressure-independent effects in rats with human renin and angiotensinogen genes. Hypertension 35: 587-594, 2000.
36. Nakamura T, Obata JE, Kimura H, Ohno S, Yoshida Y, Kawachi H, Shimizu F. Blocking angiotensin II ameliorates proteinuria and glomerular lesion in progressive mesangioproliferative glomerulonephritis. Kidney Int 55: 877-889, 1999.
37. Ortiz MC, Manriquez MC, Romero JC, Juncos LA. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension 38: 655-659, 2001.
38. Patterson ME, Mullins JJ, Mitchell KD. Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension. Am J Physiol Renal Physiol 294: F205-F211, 2008.
39. Patzak A, Steege A, Lai EY, Brinkmann JO, Kupsch E, Spielmann N, Gericke A, Skalweit A, Stegbauer J, Persson PB, Seeliger E. Angiotensin II response in afferent arterioles of mice lacking either the endothelial or neuronal isoform of nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 294: R429-R437, 2008.
40. Pech V, Sikka SC, Sindhu RK, Vaziri ND, Majid DS. Oxidant stress and blood pressure responses to angiotensin II administration in rats fed varying salt diets. Am J Hypertens 19: 534-540, 2006.
41. Reckelhoff JF, Romero JC. Role of oxidative stress in angiotensininduced hypertension. Am J Physiol Regul Integr Comp Physiol 284: R893-R912, 2003.
42. Rodríguez-Iturbe B, Franco M, Tapia E, Quiroz Y, Johnson RJ. Renal inflammation, autoimmunity and salt-sensitive hypertension. Clin Exp Pharmacol Physiol 10: 1440-1681, 2011.
43. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, Egido J. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 82: S12-S22, 2002.
44. Shahid M, Francis J, Majid DSA. Tumor necrosis factor-alpha induces renal vasoconstriction as well as natriuresis in mice. Am J Physiol Renal Physiol 295: F1836-F1844, 2008.
45. Shahid M, Francis J, Matrougui K, Majid DSA. Involvement of TNF-κ in the natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice. Am J Physiol Renal Physiol 299: F217-F224, 2010.
46. Singh P, Castillo A, Johnson RA, Majid DSA. Reduction in interleukin-10 level in plasma and in renal tissue during systemic inhibition of nitric oxide synthase in anesthetized mice. Hypertension 60: A182, 2012.
47. Singh P, Stephenson R, Majid DSA. Changes in plasma, and renal tissue levels of inflammatory cytokines during chronic high salt intake in wildtype and eNOS knockout mice. J Invest Med 61; 484: A392, 2013.
48. Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-α in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 51: 1345-1351, 2008.
49. Stegbauer J, Kuczka Y, Vonend O, Quack I, Sellin L, Patzak A, Steege A, Langnaese K, Rump LC. Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release. Am J Physiol Regul Integr Comp Physiol 294: R421-R428, 2008.
50. Thomassen MJ, Buhrow LT, Connors MJ, Kaneko FT, Erzurum SC, Kavuru MS. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol 17: 279-283, 1997.
51. Yamaguchi H, Kidachi Y, Umetsu H, Ryoyama K. L-NAME inhibits tumor cell progression and pulmonary metastasis of r/m HM-SFME-1 cells by decreasing NO from tumor cells and TNF-κ from macrophages. Mol Cell Biochem 312: 103-112, 2008.
52. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 88: 947-953, 2001.
53. Wenzel S, Rohde C, Wingerning S, Roth J, Kojda G, Schlüter KD. Lack of endothelial nitric oxide synthase-derived nitric oxide formation favors hypertrophy in adult ventricular cardiomyocytes. Hypertension 49: 193-200, 2007.
54. Zhang GG, Bai YP, Chen MF, Shi RZ, Jiang DJ, Fu QM, Tan GS, Li YJ. Asymmetric dimethylarginine induces TNF-κ production via ROS/NF-κB-dependent pathway in human monocytic cells and the inhibitory effect of reinioside C. Vascul Pharmacol 48: 115-121, 2008.